IgA nephropathy: open trials in Brazil

• NCT07146906

  A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

  Trial Treatment · Phase 2 · Novartis Pharmaceuticals

  Botucatu · Natal · Recife · Serra

  Registry updated 2026-10-21

• NCT06935357

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  Trial Treatment · Phase 3 · Biogen

  Irmandade da Santa Casa de Misericórdia de Belo Horizonte - PPDS, Belo Horizonte · Freire Pesquisa Clinica, Belo Horizonte · Fundação Universidade de Caxias do Sul - Instituto de Pesquisas em Saúde, Caxias do Sul · Centro Mineiro de Pesquisa - CMiP, Juiz de Fora · Hospital de Clinicas de Porto Alegre HCPA PPDS, Porto Alegre · Hospital Alemao Oswaldo Cruz (HAOC), São Paulo · Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo

  Registry updated 2026-10-14

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Belo Horizonte · Curitiba · Porto Alegre · São José do Rio Preto · São Paulo

  Registry updated 2026-10-05

• NCT06419205

  A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

  Trial Treatment · Phase 2 · Akebia Therapeutics

  São Paulo

  Registry updated 2026-10-01

All IgA nephropathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error